GERON CORP

GERN

GERON CORP

GERN

Insider Sentiment (TTM):

Last Purchase:2025-05-09Last Sale:2026-02-18Shares Purchased (TTM):0Shares Sold (TTM):9,855

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:489,723,725Shares Outstanding:669,375,000Institutional Ownership Pct.:73.16%

Earnings Market Reaction:

Filing Date:2026-08-05Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	63	69	78	78	78	84	79	60	117	190	70	31
Restricted Cash And Cash Equivalents At Carrying V…	2	2	2	2	2	2	2	2	1	1	1	1
Available For Sale Securities Debt Securities Curr…	-	-	-	-	-	-	328	279	246	253	264	283
Debt Securities Available For Sale Excluding Accru…	238	244	280	302	310	313	328	-	-	-	-	-
Accounts Receivable Net Current	52	42	37	35	37	31	36	28	1	-	-	-
Nontrade Receivables Current	2	2	2	2	3	3	3	2	2	2	2	15
Inventory Net	124	133	117	95	69	56	39	20	1	-	-	-
Prepaid Expense And Other Assets Current	6	7	5	7	7	7	5	6	6	6	5	6
Assets Current	486	499	520	522	506	496	491	398	373	452	341	335
Available For Sale Securities Debt Securities Nonc…	-	-	-	-	-	-	95	37	67	21	43	68
Debt Securities Available For Sale Excluding Accru…	24	27	41	39	43	59	95	-	-	-	-	-
Property Plant And Equipment Net	1	1	1	1	1	1	1	2	2	2	1	1
Operating Lease Right Of Use Asset	2	2	2	2	3	3	3	3	3	3	4	4
Assets	519	534	571	567	555	562	594	445	449	482	394	413
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	9	13	11	11	8	8	9	14	6	10	6	14
Employee Related Liabilities Current	9	9	30	16	11	10	23	15	11	7	14	11
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Debt Current	-	-	-	-	-	0	-	72	47	72	47	22
Accrued Liabilities Current	31	31	51	40	26	29	36	36	39	34	40	42
Liabilities Current	70	74	112	88	64	63	88	138	104	123	108	89
Operating Lease Liability Noncurrent	1	1	1	2	2	2	2	2	3	3	3	3
Long Term Debt Noncurrent	120	120	120	119	119	119	118	12	37	11	35	30
Liabilities	300	305	345	-	-	-	313	-	-	-	146	-
Stockholders Equity
Preferred Stock Value	0	0	0	-	-	-	0	-	-	-	-	-
Common Stock Value	1	1	1	1	1	1	1	1	1	1	1	1
Additional Paid In Capital Common Stock	2,094	2,088	2,081	2,075	2,067	2,059	2,052	2,038	2,027	1,998	1,845	1,837
Retained Earnings Accumulated Deficit	-1,876	-1,859	-1,856	-1,827	-1,809	-1,792	-1,772	-1,747	-1,721	-1,653	-1,598	-1,546
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	0	0	0	0	0	1	-1	-0	0	-1
Stockholders Equity	219	229	226	249	260	268	280	292	307	345	248	291
Liabilities And Stockholders Equity	519	534	571	567	555	562	594	445	449	482	394	413
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	-	-	-	0.001	-	-	-	0.001	-
Preferred Stock Shares Authorized	-	-	3	-	-	-	3	-	-	-	3	-
Preferred Stock Shares Issued	-	-	0	-	-	-	0	-	-	-	0	-
Preferred Stock Shares Outstanding	-	-	0	-	-	-	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	-	-	-	0.001	-	-	-	0.001	-
Common Stock Shares Authorized	-	-	1,350	-	-	-	1,350	-	-	-	1,350	-
Common Stock Shares Issued	-	-	640	-	-	-	606	-	-	-	545	-
Shares Outstanding	-	-	640	-	-	-	606	-	-	-	545	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-20.89%	-16.46%	-10.13%	-	-	-	-	-	-	-	-	-
2025	16.03%	13.74%	-3.82%	0.72%	-7.19%	-10.79%	10.28%	28.04%	28.97%	-9.68%	-3.23%	-17.42%
2024	-11.90%	17.72%	16.46%	3.26%	-0.65%	-11.74%	-3.96%	-21.91%	-29.84%	4.60%	-27.01%	-27.01%
2023	-	-	-	-	-	-	10.67%	28.65%	6.18%	69.74%	89.23%	95.38%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	6.92	6.78	4.66	5.96	7.87	7.87	5.56	2.89	3.61	3.67	3.16	3.75
Quick Ratio	5.07	4.87	3.58	4.79	6.68	6.86	5.06	2.69	3.54	3.62	3.11	3.68
Working Capital	416.01M	424.96M	408.73M	434.63M	441.31M	432.74M	402.69M	260.12M	269.77M	328.35M	233.28M	245.70M
Leverage & Debt
Debt to Equity	1.37	1.33	1.53	0.35	0.25	0.23	1.12	0.47	0.34	0.36	0.59	0.31
Interest Coverage TTM	-1.71	-1.64	-2.10	-1.85	-2.72	-5.77	-9.39	-17.16	-20.41	-21.38	-23.33	-22.71
Debt Ratio	0.58	0.57	0.60	0.15	0.12	0.11	0.53	0.31	0.23	0.26	0.37	0.22
Efficiency & Turnover
Asset Turnover TTM	0.38	0.36	0.32	0.36	0.33	0.22	0.15	0.07	0.00	0.00	0.00	0.00
Days Sales Outstanding TTM	78.83	68.07	72.49	63.23	41.72	98.24	171.52	349.57	280.82	-	-	-
Receivables Turnover TTM	4.63	5.36	5.04	5.77	8.75	3.72	2.13	1.04	1.30	-	-	-
Per Share Metrics
Diluted EPS TTM	-0.10	-0.10	-0.13	-0.12	-0.13	-0.21	-0.27	-0.30	-0.34	-0.33	-0.32	-0.30
Free Cash Flow Per Share TTM	-0.17	-0.19	-0.17	-0.20	-0.27	-0.31	-0.34	-0.33	-0.32	-0.31	-0.30	-0.28
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	-	124.19%	141.44%	1,080.55%	3,571.02%	-	2,622.40%
Operating Profit Margin TTM	-25.34%	-26.41%	-37.35%	-34.50%	-47.22%	-115.98%	-227.12%	-711.18%	-20,014.79%	-74,200.00%	-	-57,288.96%
Net Profit Margin TTM	-33.09%	-34.37%	-45.47%	-43.73%	-53.68%	-120.06%	-228.21%	-688.00%	-19,326.67%	-71,164.31%	-	-55,138.49%
Growth Metrics
Net Revenue Growth (1Y)	24.61%	69.14%	140.05%	525.46%	14,332.04%	40,816.61%	-	9,124.92%	152.44%	-42.71%	-100.00%	-79.32%
Net Income Growth (1Y)	-23.18%	-51.58%	-52.17%	-60.24%	-59.91%	-30.97%	-5.19%	15.11%	28.37%	34.33%	29.76%	33.14%
EPS Growth (1Y)	-23.69%	-51.83%	-53.65%	-60.54%	-60.65%	-37.44%	-16.25%	0.74%	7.44%	21.19%	-13.41%	-6.90%
Valuation Metrics
P/E TTM	-12.70	-14.82	-10.54	-11.43	-10.67	-7.62	-13.10	-14.94	-12.63	-9.89	-6.54	-7.03
P/B TTM	3.93	4.35	3.90	3.67	3.62	3.95	8.16	10.29	9.04	5.77	4.86	4.23
P/S TTM	4.20	5.09	4.79	5.00	5.73	9.14	29.90	102.80	2,440.63	7,037.20	-	3,875.58
Market Cap	858.49M	997.37M	880.00M	913.93M	939.30M	1.06B	2.29B	3.01B	2.77B	1.99B	1.20B	1.23B
Enterprise Value	915.98M	1.05B	921.98M	955.08M	980.56M	1.09B	2.33B	3.03B	2.74B	1.88B	1.22B	1.25B
Calculated Values
Free Cash Flow TTM	-114.38M	-125.96M	-111.04M	-133.06M	-178.42M	-204.69M	-219.58M	-216.50M	-208.59M	-184.70M	-168.57M	-162.89M
Net Debt	57.49M	50.94M	41.99M	41.15M	41.26M	34.98M	39.46M	23.49M	-33.51M	-107.02M	11.92M	21.19M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-02-18Sale

Owner: Robertson, Michelle

Title: EVP, CHIEF FINANCIAL OFFICER

Shares: 9,855

Price/Share: $1.94

Value: $19,118.70

Shares Owned: 17,645

Relationship: Officer

Ownership: Direct

2025-05-09Purchase

Owner: Lawlis, V Bryan

Title: -

Shares: 13,300

Price/Share: $1.18

Value: $15,694.00

Shares Owned: 13,300

Relationship: Director

Ownership: Direct

2025-02-27Purchase

Owner: Samuels, Scott Alan

Title: EVP, Chief Legal Officer

Shares: 15,000

Price/Share: $1.61

Value: $24,150.00

Shares Owned: 26,682

Relationship: Officer

Ownership: Direct

2025-02-27Purchase

Owner: Ziegler, James

Title: EVP, Chief Commercial Officer

Shares: 100,000

Price/Share: $1.60

Value: $160,000.00

Shares Owned: 100,000

Relationship: Officer

Ownership: Direct

2025-02-27Purchase

Owner: Scarlett, John A

Title: Chairman, President and CEO

Shares: 12,500

Price/Share: $1.77

Value: $22,125.00

Shares Owned: 12,500

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-02-18	Robertson, Michelle	Officer	EVP, CHIEF FINANCIAL OFFICER	Direct	Sale	9,855	1.94	$19,118.70	17,645	4
2025-05-09	Lawlis, V Bryan	Director	-	Direct	Purchase	13,300	1.18	$15,694.00	13,300	4
2025-02-27	Samuels, Scott Alan	Officer	EVP, Chief Legal Officer	Direct	Purchase	15,000	1.61	$24,150.00	26,682	4
2025-02-27	Ziegler, James	Officer	EVP, Chief Commercial Officer	Direct	Purchase	100,000	1.60	$160,000.00	100,000	4
2025-02-27	Scarlett, John A	Director,Officer	Chairman, President and CEO	Direct	Purchase	12,500	1.77	$22,125.00	12,500	4
2024-07-08	Grethlein, Andrew J	Officer	EVP, Chief Operating Officer	Direct	Sale	674,348	4.56	$3,075,026.88	0	4
2024-06-10	Feller, Faye	Officer	EVP, Chief Medical Officer	Direct	Sale	287,900	4.63	$1,332,977.00	0	4
2024-06-10	Kapur, Anil	Officer	EVP, Corp Strategy & CCO	Direct	Sale	421,875	4.65	$1,961,718.75	0	4
2024-06-04	Scarlett, John A	Director,Officer	Chairman, President and CEO	Direct	Sale	600,000	4.00	$2,400,000.00	600,000	4
2024-05-15	Lawlis, V Bryan	Director	-	Direct	Sale	35,000	3.75	$131,250.00	0	4
2023-08-24	O'Farrell, Elizabeth G.	Director	-	Direct	Purchase	6,607	2.28	$15,063.96	7,407	4
2023-05-11	Lawlis, V Bryan	Director	-	Direct	Sale	35,000	3.00	$105,000.00	0	4
2023-05-01	Molineaux, Susan	Director	-	Direct	Sale	35,000	2.48	$86,800.00	0	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

73.16%

Inst. Shares: 489,723,725

Shares Outstanding: 669,375,000

2025-12-31

71.07%

Inst. Shares: 473,782,024

Shares Outstanding: 666,662,989

2025-09-30

75.04%

Inst. Shares: 500,613,175

Shares Outstanding: 667,101,756

2025-06-30

75.76%

Inst. Shares: 504,718,711

Shares Outstanding: 666,170,358

2025-03-31

75.26%

Inst. Shares: 501,157,135

Shares Outstanding: 665,905,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	489,723,725	669,375,000	73.16%
2025-12-31	473,782,024	666,662,989	71.07%
2025-09-30	500,613,175	667,101,756	75.04%
2025-06-30	504,718,711	666,170,358	75.76%
2025-03-31	501,157,135	665,905,000	75.26%
2024-12-31	480,119,387	646,033,247	74.32%
2024-09-30	497,022,384	662,158,182	75.06%
2024-06-30	450,016,985	653,904,978	68.82%
2024-03-31	428,615,619	603,493,451	71.02%
2023-12-31	388,069,683	570,645,405	68.01%
2023-09-30	360,810,667	579,508,305	62.26%
2023-06-30	329,831,922	547,280,946	60.27%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

GERON CORP (GERN) — SEC Financial Statements & Analysis

GERON CORP (GERN) is a pharmaceutical preparations company, incorporated in DE. GERON CORP trades on Nasdaq as: GERN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), GERON CORP reported a 24.61% year-over-year revenue growth, a Gross Profit Margin of 124.19% (TTM), a Debt-to-Equity ratio of 1.37x, a Price-to-Sales (P/S) ratio of 4.20x (TTM), a Price-to-Book (P/B) ratio of 3.93x (TTM), at a market cap of $858.49M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 24.61%
Gross Profit Margin TTM: 124.19%
Debt To Equity: 1.37x
P/S TTM: 4.20x
P/B TTM: 3.93x
Market Cap: $858.49M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is GERON CORP in?

GERON CORP (GERN) operates in the Pharmaceutical Preparations industry.

What is GERN's market cap?

GERON CORP (GERN) has a market capitalization of $858.49M as of 2026-06-30.

What exchange does GERN trade on?

GERON CORP (GERN) trades on the Nasdaq.

Where is GERON CORP incorporated?

GERON CORP is incorporated in DE.

GERON CORP

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

GERON CORP (GERN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

GeminIQ Research & Analysis

Wall Street's data.
Main Street's price.

GERON CORP (GERN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

GeminIQ Research & Analysis

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.